L-Tyrosine
Natural health product licensed in Canada
- Other names
- Tyrosine
- Licence holder
- Advanced Orthomolecular Research Inc.
- NPN or DIN-HM
- 80003032
- Status
- Active licence
- Licence date
- 16 March 2007
- Revision date
- 24 March 2020
- Form
- Capsule
- Route of administration
- Orale
- Application type
- (M) non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Poudre de racine de carotte, Eau, Dioxyde de silicium, Sodium Stearyl Fumarate, Lécithine, Hypromellose, Sorbitol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 6 Capsule | Not specified |
Uses authorised in Canada
Research supports L-Tyrosine's ability to help in the management of stress arising from physical or psychological origins, includng sleep deprivation and multitasking
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Supplemental l-tyrosine may increase blood pressure or lead to difficulty sleeping in some persons.
- Effets indésirables connus
Discontinue if you experience nausea, headache, fatigue, heartburn or joint pain.
- Contre-indications
Persons with hyperthyroidism, graves disease, active melanoma, or those taking dopamine, thyroid hormone medication and/or contraceptive medications, or other psychoactive medications should consult with their physicians. Do not use if you are pregnant or breastfeeding, or have the genetic metabolic disorder phenylketonuria (PKU).
Source
Official Health Canada record, licence 80003032
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2020. Photograph the packaging to check whether it has changed. Photograph the packaging